| Development of the acne-specific quality of life questionnaire Quality of Life Relevance-Acne PV Chernyshov, F Sampogna, G Raimondi, CC Zouboulis, MJ Boffa, ... JAAD international 16, 9-17, 2024 | 1 | 2024 |
| Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue Specimens AJ Sampath, LL Westerkam, FR Blum, R Alhusayen, FG Bechara, ... Journal of Investigative Dermatology, 2024 | | 2024 |
| The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis D Bouazzi, RK Andersen, GR Vinding, CE Medianfar, SM Nielsen, ... Dermatology 240 (3), 369-375, 2024 | | 2024 |
| Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa: The Cumulative IHS4 HH van der Zee, JC van Huijstee, KR van Straalen, GBE Jemec, ... Dermatology 240 (3), 514-516, 2024 | | 2024 |
| Unveiling the mechanism of photothermal therapy in acne man-agement: targeting sebaceous gland ferroptosis via umbilical cord mesenchymal stem cell membrane-encapsulated Au-Ag-PDA R Wu, J Li, H Tian, D Song, T Zhao, Y Tian, CC Zouboulis, J Jiang, M Zhu Frontiers in Bioengineering and Biotechnology 12, 1426477, 2024 | | 2024 |
| Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo … AB Kimball, GBE Jemec, CJ Sayed, JS Kirby, E Prens, JR Ingram, A Garg, ... The Lancet 403 (10443), 2504-2519, 2024 | 2 | 2024 |
| A spatial portrait of the human sebaceous gland transcriptional program M Schmidt, F Hansmann, H Loeffler-Wirth, CC Zouboulis, H Binder, ... Journal of Biological Chemistry, 107442, 2024 | | 2024 |
| S2k‐Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa–Kurzfassung CC Zouboulis, FG Bechara, K Fritz, M Goebeler, FH Hetzer, E Just, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 22 (6), 868-892, 2024 | | 2024 |
| TRPV3 promotes sebocyte inflammation via transcriptional modulating TLR2 in acne Z Wei, M Gao, Y Liu, R Zeng, J Liu, S Sun, S Li, L Hu, R Xiang, R Mo, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1870 (5), 167195, 2024 | | 2024 |
| Preparation and decolorization of sapindus mukurossi extract and its application in sebum-control shampoos K Wan, L Ma, D Chen, Z Li, CC Zouboulis, K Chang, J Wang Journal of Dermatologic Science and Cosmetic Technology 1 (2), 100006, 2024 | | 2024 |
| Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase … CC Zouboulis, T Passeron, D Pariser, MB Wozniak, X Li, L Uhlmann, ... British Journal of Dermatology 190 (6), 836-845, 2024 | 1 | 2024 |
| International hidradenitis Suppurativa severity scoring system (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: a post … CC Zouboulis, EP Prens, CJ Sayed, A Molina-Leyva, V Bettoli, ... Journal of the European Academy of Dermatology and Venereology: JEADV 38 (6 …, 2024 | 2 | 2024 |
| S2k guideline for the treatment of hidradenitis suppurativa/acne inversa–Short version CC Zouboulis, FG Bechara, K Fritz, M Goebeler, FH Hetzer, E Just, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024 | 1 | 2024 |
| Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients L Greenlund, C Herzog, Z Wendland, K Rypka, JW Frew, JS Kirby, A Alavi, ... Journal of the European Academy of Dermatology and Venereology, 2024 | | 2024 |
| Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical … A Alavi, E Prens, AB Kimball, JW Frew, JG Krueger, S Mukhopadhyay, ... British Journal of Dermatology, ljae144, 2024 | | 2024 |
| Primary Cutaneous Melanoma—Management in 2024 AJ Dixon, M Sladden, CC Zouboulis, CM Popescu, A Nirenberg, ... Journal of Clinical Medicine 13 (6), 1607, 2024 | | 2024 |
| Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose … JS Kirby, MM Okun, A Alavi, FG Bechara, CC Zouboulis, K Brown, ... Journal of the American Academy of Dermatology 90 (3), 521-529, 2024 | 4 | 2024 |
| Exosomes from adipose-derived stem cells activate sebocytes through the PI3K/AKT/SREBP-1 pathway to accelerate wound healing Y Zhang, CC Zouboulis, Z Xiao Cell and Tissue Research, 1-14, 2024 | | 2024 |
| Spatial transcriptomics reveals altered lipid metabolism and inflammation-related gene expression of sebaceous glands in psoriasis and atopic dermatitis P Seiringer, C Hillig, A Schäbitz, M Jargosch, AC Pilz, S Eyerich, ... Frontiers in immunology 15, 1334844, 2024 | 1 | 2024 |
| Significant spontaneous daily fluctuation of inflammatory nodules and abscesses but not of draining tunnels in hidradenitis suppurativa/acne inversa. CC Zouboulis, EJ Giamarellos-Bourboulis, GBE Jemec, AC Katoulis, ... Journal of the European Academy of Dermatology and Venereology: JEADV, 2024 | | 2024 |
Gregor JemecUniversity of Copenhagen在 regionsjaelland.dk 的电子邮件经过验证
